The Calmer Co. Surges 86% to $8M, Launches Flavoured Kava Shots on Amazon USA

Robust Growth Across Channels

The Calmer Co. International Limited (ASX, CCO) has delivered a remarkable FY25 revenue result, exceeding AU$8 million; an 86% increase compared to the previous year’s AU$4.3 million. This marks the company’s third consecutive year of strong growth, driven by a well-diversified sales strategy spanning direct-to-consumer, retail, Amazon USA, and wholesale channels.

Direct-to-consumer sales accounted for 39% of revenue, while retail contributed 30%, Amazon USA 23%, and wholesale 8%. The company’s expanding footprint in major Australian supermarkets is notable, with Taki Mai Kava Shots now stocked in 797 Coles stores and FijiKava Instant Kava in over 1,900 stores across Coles and Woolworths, the country’s largest supermarket chains.

Strategic US Market Expansion

The Calmer Co. is accelerating its US market penetration with the launch of five new flavoured Taki Mai Kava Shots exclusively on Amazon USA. These ready-to-drink shots, available in tropical and dessert-inspired flavours such as Coconut and Choc Banana, aim to broaden appeal among American consumers seeking natural, alcohol-free relaxation alternatives.

Amazon USA subscriptions now represent 28% of the company’s Amazon sales volume, underscoring strong customer loyalty and repeat purchasing. The brand’s market share on Amazon increased sharply from 6% in January to 24% by April 2025, reflecting growing consumer traction. Amazon forecasts a 45% growth in kava sales over the next year, aligning with The Calmer Co.’s strategic focus on this high-potential market.

Product Mix and Channel Diversification

The introduction of flavoured kava shots complements the company’s existing tincture extracts and signals a shift towards ready-to-drink formats, which currently represent 7.3% of revenue but are expected to grow significantly. The company’s logistics strategy leverages a Houston-based fulfilment centre alongside Amazon’s fulfilment services, enabling efficient nationwide distribution in the US.

Wholesale partnerships have also been strengthened, including collaboration with IMCD and entry into the US kava bar market through a partnership with Leilo. This diversified channel approach supports sustainable volume growth and reduces reliance on any single sales avenue.

Outlook and Market Positioning

Founder and CEO Zane Yoshida highlighted the milestone of crossing AU$8 million in revenue as a testament to the company’s multichannel strategy and team dedication. The Calmer Co. is positioning itself as a leader in the natural relaxation and alcohol alternative space, capitalising on growing consumer trends in both Australia and the US.

With the US market estimated to be 13 times larger than Australia and the kava category gaining mainstream acceptance, The Calmer Co.’s expansion and product innovation efforts could unlock substantial growth opportunities in the coming years.